1-212615181-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001674.4(ATF3):c.160C>T(p.Leu54Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001674.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATF3 | NM_001674.4 | c.160C>T | p.Leu54Phe | missense_variant | 2/4 | ENST00000341491.9 | NP_001665.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATF3 | ENST00000341491.9 | c.160C>T | p.Leu54Phe | missense_variant | 2/4 | 1 | NM_001674.4 | ENSP00000344352.4 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152186Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251474Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135910
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727248
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152186Hom.: 0 Cov.: 30 AF XY: 0.000121 AC XY: 9AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 01, 2023 | The c.160C>T (p.L54F) alteration is located in exon 2 (coding exon 1) of the ATF3 gene. This alteration results from a C to T substitution at nucleotide position 160, causing the leucine (L) at amino acid position 54 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at